Results for tag: "Mantle Cell Lymphoma Drug"

Mantle Cell Lymphoma (MCL) is a rare type of non-Hodgkin lymphoma that affects the B-cells of the immune system. It is an aggressive form of cancer that is difficult to treat and has a poor prognosis. Treatment options for MCL include chemotherapy, radiation therapy, and targeted therapies such as monoclonal antibodies and small molecule drugs. The Mantle Cell Lymphoma Drug market is a subset of the larger Lymphoma Drugs market. It is composed of drugs specifically designed to treat MCL, such as ibrutinib, lenalidomide, and bortezomib. These drugs are used to reduce tumor size, improve symptoms, and prolong survival. The companies in the Mantle Cell Lymphoma Drug market include AbbVie, Celgene, Janssen, and Novartis. These companies are involved in the research, development, and marketing of drugs for the treatment of MCL. Show Less Read more